Transformants releasing E␤C suffered less damage than control lines when EPNs were present. (A) Root damage measured on plants that had received neither WCR eggs nor nematodes was minimal, and there was no difference between transformed and nontransformed plants (n ϭ 5, P ϭ 0.87). (B) Root damage on plants that received only WCR eggs, but no nematodes, was substantial. Again, no significant difference was found between the transformed and nontransformed plants (n ϭ 5, P ϭ 0.18). (C) In plots that received WCR eggs and H. megidis, roots from transformed plants (pooled) had significantly less damage than roots from control lines (n ϭ 30, P ϭ 0.007). Approximately one-quarter of the transformed plants were found not to emit E␤C. Removing these plants from the statistical analysis did not significantly affect the results. The letters above the bars indicate significant differences within a graph. Error bars indicate standard errors.
Fig. 2.
Transformants releasing E␤C suffered less damage than control lines when EPNs were present. (A) Root damage measured on plants that had received neither WCR eggs nor nematodes was minimal, and there was no difference between transformed and nontransformed plants (n ϭ 5, P ϭ 0.87). (B) Root damage on plants that received only WCR eggs, but no nematodes, was substantial. Again, no significant difference was found between the transformed and nontransformed plants (n ϭ 5, P ϭ 0.18). (C) In plots that received WCR eggs and H. megidis, roots from transformed plants (pooled) had significantly less damage than roots from control lines (n ϭ 30, P ϭ 0.007). Approximately one-quarter of the transformed plants were found not to emit E␤C. Removing these plants from the statistical analysis did not significantly affect the results. The letters above the bars indicate significant differences within a graph. Error bars indicate standard errors. is not yet completely understood. Although this protein has been suggested to play a role in synaptic vesicle biogenesis, modulation of synaptic transmission, and brain lipid metabolism, involvement of ␣-synuclein in the pathogenesis of neurodegenerative diseases has been established clearly (1) . In several forms of inherited Parkinson's disease (PD), three missense mutations and gene multiplications have been linked to SNCA, the gene encoding ␣-synuclein protein (2) . Amyloid fibril forms of ␣-synuclein aggregates are the main constituents of Lewy bodies (LBs) and Lewy neurites in PD and several other LB diseases (3) . Overproduction of the wild-type protein or mutant variants in several model organisms results in neurodegeneration and Lewylike inclusion formation (4) . The tight association between ␣-synuclein aggregation and neurodegenerative phenotypes in human patients and animal models and the fact that accelerated aggregation is a common outcome of all known ␣-synuclein mutations (5) strongly highlight the importance of abnormal aggregation of this protein in the pathogenesis of PD and related LB diseases.
Parkinson's disease primarily is defined as a movement disorder associated with degeneration of dopaminergic neurons in the nigrostriatal system (6). However, its pathology involves the progressive neuronal accumulation of aggregated ␣-synuclein, and the formation of LBs affects various functional structures throughout the human nervous system (7), leading to serious cognitive and behavioral alterations. In a large proportion of PD cases, accumulation of aggregated ␣-synuclein undergoes an ascending and highly predictable pattern of progression, spreading from the lower brainstem and olfactory bulb into the limbic system and, eventually, to the neocortex (8), suggesting a mechanism involving pathological propagation, similar to the one observed in prion diseases. The idea of pathological propagation recently has gained much attention after two studies showed the host-to-graft propagation of ␣-synuclein-positive Lewy-like pathology in long-term mesencephalic transplants in PD (9, 10) , results that have a profound impact on cell-based therapies. Despite this, the underlying mechanism of the initiation and propagation of ␣-synuclein pathology is unknown, and whether the previously proposed direct interneuronal transmission of ␣-synuclein aggregates actually occurs has not been determined (11, 12) .
We previously have found that a small but significant proportion of ␣-synuclein and its aggregates are secreted from neuronal cells via exocytosis (13) . Moreover, upon exposure, neurons in culture are capable of taking up ␣-synuclein aggregates via endocytosis (14, 15) . On the basis of these observations, we tested the hypothesis that ␣-synuclein pathology can be propagated by direct neuron-to-neuron transmission of ␣-synuclein aggregates.
tate patterns of cytoplasmic accumulation of human ␣-synuclein (Fig. 1C) .
Next, we analyzed the propagation of ␣-synuclein to transplanted stem cells in vivo. For this purpose, GFP-labeled MCNSCs were injected into the hippocampus ( Fig. 2A ) of transgenic mice (line 61) expressing human ␣-synuclein under the control of the Thy-1 promoter (16) . One week postinjection, Ϸ2.5% of the grafted GFP-labeled MCNSCs showed human ␣-synuclein immunoreactivity ( Fig. 2 B and C) , whereas the MCNSCs grafted into nontransgenic mice tested negative for human ␣-synuclein (Fig. 2 D and E) . After 4 weeks, the percentage of human ␣-synuclein-positive MCNSCs increased to 15% (Fig. 2G) , and a few of these cells developed compact inclusion bodies within the cytoplasm (Fig. 2F) . These results suggest that ␣-synuclein pathology can be transmitted directly from host to grafted cells.
We then examined the ultrastructural features of the inclusion bodies formed in the grafted cells. The electron-dense inclusion bodies were apparent in the MCNSCs transplanted into human ␣-synuclein transgenic mice but not in the ones grafted into nontransgenic mice (Fig. S1 ). The number of grafted cells containing inclusion bodies increased with time after engraftment such that after 1 week cells rarely contained inclusion bodies; however, after 4 weeks, cells containing inclusion bodies were quite common (Fig. S1G) . These structures were composed of vesicular and amorphous electron-dense material, with no apparent fibrils (Fig. S1F ).
Inclusion Body Formation via Cell-to-Cell Transmission of ␣-Synuclein.
To further characterize the cell-to-cell transmission of ␣-synuclein, we established an in vitro coculture model. In this model, two populations of human dopaminergic neuronal cells (derived from SH-SY5Y neuroblastoma cells) were cocultured: one overexpressing myc-tagged ␣-synuclein (donor cells) and the other labeled with Qtracker without ␣-synuclein overexpression (acceptor cells). The myc tag was used to trace the donor-derived ␣-synuclein proteins. After 24 h of coculture, transmission of myc-tagged ␣-synuclein from the donor cells was detected in the acceptor cells (Fig. 3A) . The number of acceptor cells that contain the donor-derived ␣-synuclein increased in proportion to the ␣-synuclein expression levels in donor cells. In addition, in some acceptor neuronal cells, donor-derived ␣-synuclein formed juxtanuclear inclusion bodies, with increasing numbers directly correlated with increasing expression levels in donor cells (Fig. 3A) . Approximately half of these inclusion bodies displayed ubiquitin immunoreactivity and were labeled with thioflavin S, similar to human LBs (Fig. 3C) . The inclusion bodies typically formed at later time points, suggesting that prolonged transmission of ␣-synuclein caused the inclusion body formation (Fig. 3B) . To examine the potential involvement of donor cell membrane leakage, we performed the lactate dehydrogenase release assay, with the cells overexpressing ␤-galactosidase, ␣-synuclein, or myc-tagged ␣-synuclein. We were not able to detect a significant degree of membrane leakage in any of these cases, suggesting that cell-to-cell transmission occurs without cellular membrane damage due to toxic properties of overexpressed ␣-synuclein. However, longer incubation with high levels of ␣-synuclein expression did cause donor cell death, and in such a situation, the transmission of donor-derived ␣-synuclein to acceptor cells appeared more robust. This suggests that, although neuron-to-neuron transmission of ␣-synuclein occurs without apparent cell death, degenerating neurons may accelerate the transmission, probably by acutely providing large amounts of ␣-synuclein (see SI Discussion).
␣-Synuclein inclusion bodies also were produced when neuronal cells were incubated with the conditioned medium containing secreted forms of myc-tagged ␣-synuclein (Fig. S2 A) , further demonstrating the donor-to-acceptor transmission occurring in trans, not requiring cell-to-cell contact. Immunoblot analysis demonstrated similar effects when primary neuronal cultures were incubated with the conditioned medium containing myc-tagged ␣-synuclein released from the culture of differentiated SH-SY5Y cells (Fig. S2B) . A large proportion of the transmitted ␣-synuclein was found in the Triton-insoluble fraction and appeared as SDS-resistant, large-molecular-mass complexes (Fig. S2B) .
The neuronal cells incubated with the conditioned media from the ␤-galactosidase-expressing cells and the ␣-synucleinexpressing cells were examined under an electron microscope. The cells incubated with the ␣-synuclein medium developed electron-dense inclusion bodies in the cytoplasm, frequently near the nucleus, whereas these structures were absent in control cells or cells incubated with the ␤-galactosidase medium (Fig.  S2C ). The inclusion bodies were a mixture of various discernable structures, such as vesicles and filamentous structures tangled with amorphous electron-dense material.
To determine whether the transmission of ␣-synuclein aggregates is dependent on endocytosis, dynamin-1 K44A, a dominantnegative mutant that blocks endocytic vesicle formation, was expressed in acceptor cells. When donor neuronal cells were cocultured with the acceptor cells, transmission of ␣-synuclein was reduced considerably in the cells expressing dynamin-1 K44A compared with the cells not expressing the mutant dynamin ( Fig. S3A) , supporting a role for the endocytic pathway in cell-to-cell ␣-synuclein transfer. Consistently, Ͼ90% of the internalized myc-tagged ␣-synuclein was colocalized with endosomal GTPases rab5a and rab7 in the acceptor cells (Fig. S3B) .
Failure of the Quality Control System Promotes the Accumulation of
Transmitted ␣-Synuclein. In PD, accumulation of ␣-synuclein is associated with impairment in the protein quality control systems, such as proteasomal and autophagic degradation (17, 18) . To determine the role of quality control failure in the deposition of transmitted ␣-synuclein, cells were incubated with the conditioned medium containing secreted ␣-synuclein in the presence or absence of proteasomal or lysosomal inhibitors (MG132 and bafilomycin A1, respectively). Accumulation of internalized ␣-synuclein was increased with the failure of lysosomal function, whereas proteasomal inhibition had little effect ( Fig. 4A and Fig.  S4A ). This is consistent with our previous finding that internalized ␣-synuclein aggregates are targeted to the lysosome for degradation (14) . Inclusion formation, measured as the number of cells containing inclusion bodies, also was increased by lysosomal inhibition (Fig. 4B and Fig. S4A ). Proteasomal inhibition, however, caused a slight, although not statistically significant, increase in the number of inclusions. Furthermore, we did not observe any additive effects of proteasomal and lysosomal inhibitors when combined in either transfer efficiency or inclusion formation, suggesting the specific role of lysosomes in the clearance of internalized ␣-synuclein (Fig. 4 and Fig. S4A ). Lysosomal deficiency also caused increased inclusion body formation in primary neurons (Fig. S4B) . Thus, the inclusion body formation through the uptake of extracellular ␣-synuclein is sensitive to the status of the quality control system of the cell.
Apoptosis of Neurons upon Exposure to Neuron-Derived Extracellular
␣-Synuclein. Neurotoxicity of the secreted/endocytosed ␣-synuclein has not been investigated previously. To examine toxic effects of the endocytosed ␣-synuclein, we cultured rat primary cortical neurons in the presence of conditioned medium obtained from differentiated SH-SY5Y cells overexpressing either ␣-synuclein or ␤-galactosidase, monitoring cell death by nuclear fragmentation and caspase 3 activation. Upon exposure to secreted forms of ␣-synuclein, neurons showed nuclear fragmentation and increased immunoreactivity of activated caspase 3 over the period of 3 days, demonstrating a progressive neuronal degeneration ( Fig. 5 A and B and Fig. S5 A and B) . The neurons exposed to the LacZ medium showed a slight increase in caspase 3 activation, but the difference was not statistically significant. No changes were observed in nuclear fragmentation with the LacZ medium. To determine the toxic effects of neuron-derived ␣-synuclein in vivo, we examined caspase 3 activation in the MCNSCs transplanted into the hippocampus of human ␣-synuclein transgenic mice. We found a progressive increase in the number of MCNSCs with activated caspase 3 immunoreactivity over the period of 4 weeks (Fig. 5C and Fig. S5C ). These apoptotic changes were absent in MCNSCs grafted into wildtype control animals. Furthermore, we found that only the cells that tested positive for human ␣-synuclein showed caspase 3 activation, whereas the cells that were only GFP-positive did not show caspase 3 activation.
Discussion
The data presented here suggest a mechanism leading to the formation and spread of neuronal ␣-synuclein aggregates, providing strong evidence for direct cell-to-cell propagation of ␣-synuclein. This study also shows how failure of quality control systems contributes to the transmission of abnormal ␣-synuclein and thus the propagation of synuclein pathology. These results may explain the emergence of ␣-synuclein-positive Lewy-like pathology recently reported in long-term mesencephalic trans- Error bars are SEM ( * , P Ͻ 0.05; ** , P Ͻ 0.01). plants in PD (9, 10) . If the transmission occurs through the neural connections, then this mechanism also may explain the topographical progression of Lewy pathology in PD suggested by Braak et al. (8) . In addition, we have observed that glial inclusions, common features of PD and related disorders, are formed through neuron-to-glia transmission of ␣-synuclein proteins (33) . Demonstrating the relevance of direct cell-to-cell protein transmission in the progression of PD and other synucleinopathies will be of great interest.
This unexpected behavior of ␣-synuclein raises the intriguing possibility that a subset of early ␣-synuclein aggregates and LBs may not necessarily be cell-autonomous structures. Perhaps LBs represent not only the production of its own misfolded protein but also the production of misfolded ␣-synuclein in neighboring cells. Further research on intercellular transmission of ␣-synuclein is likely to provide insights into mechanisms of disease progression and enable us to dissect the roles of external and internal ␣-synuclein proteins in inclusion body formation. The results derived from such studies may identify therapeutic targets for PD and related synucleinopathies.
Intercellular transmission of exogenous protein aggregates has been well documented in prion disorders (19) . A similar mechanism of pathological propagation has been suggested in a mouse model of Alzheimer's disease, in which injection of brain extracts from human patients with Alzheimer's disease or from older amyloid precursor protein (APP) transgenic mice with plaque pathology induced amyloid deposition in young APP mice (20) . More recently, Ren et al. showed that externally applied polyglutamine fibrils ''seed'' the aggregation of otherwise soluble polyglutamine proteins in the cytoplasm (21) . A similar mode of aggregate transmission also has been shown with extracellular tau aggregates, which internalized and induced the aggregation of intracellular protein (22) . Therefore, direct transmission of aggregated proteins may be the common fundamental principle underlying many progressive neurological diseases.
Deposition of ␣-synuclein in the human brain takes several decades. The progression of Lewy-like inclusions from host to grafted neurons in human PD patients is also age-dependent and takes Ͼ10 years. The reasons for the long latency and rate of progression in humans, compared with the animal models, are unknown. Overproduction of ␣-synuclein in our models might contribute to the accelerated transmission observed in our study compared with the human grafts. Another factor might be the way that recipient cells handle the transmitted proteins. We previously showed in cell culture that extracellular ␣-synuclein aggregates were taken up by endocytosis, transported through the endosomal pathway, and finally degraded by lysosomes (14) . In the current study, we confirmed that cell-to-cell transmission of ␣-synuclein also was mediated by endocytosis of recipient cells and that the transmitted ␣-synuclein accumulated when the recipient's lysosomes were inhibited. These results suggest that reduced lysosomal capacity of recipient cells may be in part responsible for the deposition of transmitted ␣-synuclein. Lysosomal activity decreases with aging, and mutations in lysosomal hydrolases cause neurodegeneration in several inherited lysosomal storage disorders (23, 24) . Moreover, neuronal and glial accumulation of ␣-synuclein was observed in several human lipidoses and a mouse model of GM2 gangliosidosis (25, 26) . Recently, in yeast, Caenorhabditis elegans, and rat midbrain dopamine neurons, ␣-synuclein toxicity was shown to be antagonized by ATP13A2/PARK9 (27) , whose gene product is localized in the lysosome and suspected in lysosomal function (28) . Therefore, age-associated decline of lysosomal function might be a contributing factor for inefficient clearance, and hence deposition, of transmitted ␣-synuclein.
The demonstration that stem cells are targets for cell-to-cell transmission of ␣-synuclein has profound implications in stemcell-based therapies for PD. Although soon after grafting the transplanted cells may differentiate, migrate, and become integrated in the affected areas, thus alleviating motor symptoms, the long-term beneficial effects of the grafts may be hampered by endocytosis and accumulation of extracellular ␣-synuclein derived from host neurons. Our study showed that transmission of ␣-synuclein induced what appears to be apoptosis in the grafted cells. This is consistent with previous studies showing the toxic effects of extracellular recombinant ␣-synuclein on cells (12) . Whether the cells die due to cytoplasmic accumulation of the transmitted ␣-synuclein or whether mere exposure to the host-derived ␣-synuclein might be sufficient to induce cell death is not known. However, we also should consider the possibility that the cell death observed in our study is an exaggerated phenotype only present in overexpression-based systems, because no apparent cell death was observed in human transplantation cases (9, 10, 29) . Nevertheless, our data suggest that functional and structural deterioration of the grafted cells by long-term exposure to the host-derived extracellular ␣-synuclein in the disease milieu cannot be ruled out. In the human graft studies, Kordower and colleagues reported a reduction in dopamine transporter and tyrosine hydroxylase in grafted dopamine neurons (9, 30) , implicating a functional decline in the long-term graft. Knowledge of the molecular basis of the intercellular transmission of ␣-synuclein therefore will enable us to develop therapeutic strategies based on the manipulation of ␣-synuclein uptake in the stem cells to generate grafts with improved and long-lasting effects.
Materials and Methods

Materials. The sources of all reagents can be found in the SI Materials and Methods.
Cell Culture and ␣-Synuclein Expression. Maintenance and differentiation of the human neuroblastoma cell line SH-SY5Y, preparation of primary cortical neurons, and procedures for ␣-synuclein expression using recombinant adenoviral vectors are described in ref. 31 
Preparation of Conditioned Medium and Uptake of Extracellular ␣-Synuclein.
The procedures for conditioned media preparations and subsequent uptake experiments are described in SI Materials and Methods.
Injection of MCNSCs into Mouse Brains.
A total of 36 ␣-synuclein transgenic mice and 36 nontransgenic mice received 2 L of cell suspension (MCNSCs infected with lentivirus-GFP at a multiplicity of infection of 30) injected unilaterally (Ϸ1 ϫ 10 5 cells per mouse) stereotaxically into the hippocampus or a sham control injection. Groups of 12 ␣-synuclein transgenic (n ϭ 6 with cell suspension and n ϭ 6 sham injection) and 12 nontransgenic mice (n ϭ 6 with cell suspension and n ϭ 6 sham injection) were killed 1, 2, and 4 weeks postinjection. Procedures for cell preparation and analyses are described in SI Materials and Methods.
Immunohistochemistry, Immunofluorescent Cell Staining, and Image Analysis. The procedure for cell staining has been described elsewhere (32) It has been previously shown that ␣-synuclein is released from neuronal cells in small amounts, suggesting that this is a selective process (1) . Our recent study showed that release of ␣-synuclein and its aggregates was promoted under various protein misfolding stresses, such as mitochondrial deficit, oxidative stress, and protein clearance deficits (2) . Consistent with the idea of preferential release of misfolded/damaged proteins, mass spectrometry analysis of ␣-synuclein-derived peptides showed that the ␣-synuclein protein released into the culture media was more heavily carbonylated than the ␣-synuclein form present in the cells (2) . From these results, we speculate that ␣-synuclein release is a process by which neurons discard damaged proteins from their cytoplasm. The released ␣-synuclein and its aggregates are then cleared from the extracellular space by various proteases and by endocytosis into adjacent cells (3) . We have shown that extracellular ␣-synuclein aggregates were taken up by brain cells, including neurons and glia, and later degraded (4). However, when the presence of extracellular ␣-synuclein is sustained and exceeds the capacity of neighboring cells to degrade it, this protein may accumulate and form pathological inclusion bodies in the acceptor cells.
The results presented in the current study, showing cell-to-cell transmission of ␣-synuclein without membrane leakage from donor cells, were performed under controlled conditions of membrane leakage, although they do not rule out the possibility of transmission by the leakage of ␣-synuclein from injured neurons. Considering that neurons are progressively damaged in disease-inflicted brain, it is possible that the ␣-synuclein released from dying neurons through nonspecific membrane leakage might be a significant source of the extracellular pool and thus contribute to the propagation of ␣-synuclein pathology.
SI Materials and Methods. Materials. All-trans retinoic acid, thioflavin S, Z-Leu-Leu-Leu-al (MG132), and heparin were purchased from Sigma. Bafilomycin A1 was from Calbiochem. Fibroblast growth factor 2 (FGF2) and epidermal growth factor (EGF) were purchased from Millipore. The dynamin K44A/ pCB1 vector was a kind gift from Marc Caron (Duke University, Durham, NC). Qtracker 585 cell labeling kit was from Invitrogen. The following primary antibodies were used: myc polyclonal antibody (Abcam), myc monoclonal antibody (Invitrogen), FLAG polyclonal antibody (Sigma), dynamin monoclonal antibody (BD Biosciences), ubiquitin polyclonal antibody (Chemicon), Rab5a polyclonal antibody (Santa Cruz Biotechnology), Rab7 polyclonal antibody (Santa Cruz Biotechnology), cleaved caspase 3 antibody (Cell Signaling Technology). The lactate dehydrogenase (LDH) assay kit was from Promega. Cell culture and ␣-synuclein expression. Maintenance and differentiation of the human neuroblastoma cell line SH-SY5Y were described in ref. 5 . Rat B103 neuroblastoma cells were grown on DMEM supplemented with 10% FBS and 1% penicillinstreptomycin, in a 37°C incubator with 5% CO 2 . Primary cortical neurons were prepared from E16 embryos of pregnant SpragueDawley rats as described in ref. 5 . For ␣-synuclein expression in differentiated SH-SY5Y cells, a recombinant adenoviral vector containing human ␣-synuclein cDNA (adeno/␣-syn) and myctagged ␣-synuclein cDNA (adeno/␣-synmychis) was used as described in ref. 4 . For mouse cortical neural stem cell (MCNSC) culture, primary neural stem cells isolated from the cortices of E15-E18 C57/BL6 mice were grown as monolayers on polyornithine/laminin-coated plates in neuronal progenitor cell expansion media [DMEM/F-12 (Mediatech), 2% B27 supplement, 2 mM L-glutamine (Invitrogen), and 1% penicillinstreptomycin (Invitrogen)] supplemented with 20 ng/mL FGF2, 20 ng/mL EGF, and 2 g/mL heparin. Cells were grown in a 37°C incubator with 5% CO 2 . Coculture of donor and acceptor cells. For mixed culture of ␣-synuclein donor and acceptor cells, differentiated SH-SY5Y cells (acceptor cells) were added to SH-SY5Y cells infected with adeno/␣-syn or adeno/lacZ (donor cells) on day 1 of infection and grown for 3 days. To distinguish between donor and acceptor cells in some experiments, acceptor cells were labeled with the Qtracker 585 cell labeling kit (Invitrogen) following the supplier's protocol prior to mixing with other cells. For expression of dynamin K44A, differentiated SH-SY5Y cells (acceptor cells) were transfected with dynamin K44A/pCB1 using Lipofectamine 2000 a day before culturing with ␣-synuclein donor cells.
Rat B103 neuroblastoma cells were infected with a lentivirus-␣-synuclein at a multiplicity of infection (MOI) of 20. The MCNSCs were grown in expansion media and infected with a lentivirus-GFP at an MOI of 20, as described below for mice injections. Two days after infections, cells were coplated on polyornithine/laminin-coated glass coverslips at a density of 3 ϫ 10 4 cells per mL per cell line (total density of 6 ϫ 10 4 cells per mL) in expansion media. Cells were grown for 24 or 48 h and fixed with paraformaldehyde, followed by immunocytochemical analysis. Preparation of conditioned medium. For collection of the conditioned medium, differentiated SH-SY5Y cells infected with adeno/␣-synmychis were used. On day 2 of infection, the medium was replaced with serum-free DMEM after washing three times with DMEM. After overnight incubation at 37°C, the conditioned medium was collected and centrifuged at 1,000 ϫ g for 10 min, and the supernatant was centrifuged further at 10,000 ϫ g to remove debris and dead cells. The recovered supernatant was concentrated 10-to 20-fold using 10,000 molecular weight cut-off filters (Millipore). Uptake of extracellular ␣-synuclein. For uptake of ␣-synuclein from conditioned media, differentiated SH-SY5Y cells were treated with the 5-fold concentrated conditioned medium from cells overexpressing myc-tagged ␣-synuclein on day 5 of differentiation and grown for 3 days. For uptake of recombinant ␣-synuclein in MCNSCs, human ␣-synuclein (Calbiochem) was incubated overnight at 37°C to obtain oligomers before labeling with Alexa Fluor 488 (Invitrogen) as per the manufacturer's instructions. Protein concentration and labeling efficiency were monitored by absorbance at 280 and 420 nm. The MCNSCs were plated on polyornithine/laminin-coated glass coverslips at a density of 3 ϫ 10 4 cells per mL. Cells were incubated with expansion media containing 0.3 M Alexa-Fluor-488-labeled ␣-synuclein for 24 or 48 h. Cells were fixed with 4% paraformaldehyde in PBS before being observed under an MRC1024 confocal laser scanning microscope (Bio-Rad). LDH assay. To determine the membrane integrity of cells used in the experiments, released LDH levels were measured in the culture supernatant as described in the manufacturer's instructions (Promega). Injection of MCNSCs into mice brains. We used line 61 transgenic mice overexpressing the human ␣-synuclein gene driven by the Thy-1 promoter (6). ␣-Synuclein expression was increased by 4-fold in mice brains and was detected at both mRNA and protein levels. For grafting of stem cells in mice brains, MCNSCs (1 ϫ 10 6 cells) were infected with lentivirus-GFP at an MOI of 30. Cells were passaged 2 days later and cultured for an additional 2 days before injection (4 days after initial infection). The GFP expression was assessed by fluorescent microscopy directly before injection. Approximately 1 ϫ 10 7 cells were dissociated in 6 mL of Accutase (Millipore) for 10 min at 37°C, with occasional pipetting to disrupt cell clumps. Cells were washed once in 10 mL of PBS, and after being pelleted by centrifugation, cells were resuspended in PBS with 20 ng/mL EGF at a concentration of 5 ϫ 10 4 cells per L. Cells were kept on ice during injections, and the suspension was pipetted gently every 5-10 min. A total of 36 ␣-synuclein transgenic mice and 36 nontransgenic mice received 2 L of cell suspension injected unilaterally (Ϸ1 ϫ 10 5 cells per mouse) stereotaxically into the hippocampus or a sham control injection. Groups of 12 ␣-synuclein transgenic (n ϭ 6 with cell suspension and n ϭ 6 sham injection) and 12 nontransgenic mice (n ϭ 6 with cell suspension and n ϭ 6 sham injection) were killed 1, 2, and 4 weeks postinjection. To confirm that cells still expressed GFP and were viable after the completion of injections, GFP expression was assessed by fluorescent microscopy, and the remaining cells were plated under normal expansion culture conditions and were observed to be viable and proliferative after an additional 2 days in culture. Mice were killed following the National Institutes of Health recommendation for humane treatment of animals. Immunohistochemistry and image analysis. The brains were fixed in paraformaldehyde and serially sectioned with a Vibratome (Leica), and every third section was immunostained with antibodies against ␣-synuclein or activated caspase 3 (Cell Signaling Technology), detected with the Tyramide Signal AmplificationDirect (Red) system (1:100; NEN Life Sciences) followed by imaging with a confocal laser scanning microscope. Slides were covered with the Prolong Gold antifading reagent with DAPI (Invitrogen). From each case, a total of three random sections across the site of the injection were analyzed with the StereoInvestigator system (MBF Bioscience) to determine the proportion of the GFP-positive cells that exhibited ␣-synuclein or activated caspase 3 at the different time points. Immunofluorescent cell staining. The procedure for cell staining has been described elsewhere (7) . Briefly, cells grown on poly(Llysine)-coated coverslips were fixed in 4% paraformaldehyde in PBS and permeabilized in 0.1% Triton X-100. Cells were incubated in blocking solution (5% BSA/3% goat serum in PBS) before incubation with primary antibodies diluted in blocking solution. After being washed in PBS, cells were incubated with the fluorescent dye (Cy2-, Rhodamine Red X)-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) and then washed again in PBS. The nuclei were stained with TOPRO-3 dye (Invitrogen), and the coverslips were mounted on slides in Antifade reagent (Invitrogen). For thioflavin S staining, fixed cells were incubated with 0.05% thioflavin S in PBS for 8 min and washed three times in 80% ethanol for 5 min each before proceeding with remaining staining procedures. Cells were observed under an Olympus FV1000 confocal laser scanning microscope, and the fluorescence intensity was quantified using FV10-ASW 1.7 software (Olympus). The graphs of fluorescence intensity and inclusion body number were prepared using GraphPad Prism 4 and Instat software. For MCNSC experiments, immunocytochemical analysis was performed using antibodies against ␣-synuclein detected with the Tyramide Signal Amplification-Direct (Red) system (1:100; NEN Life Sciences), and cells were mounted on slides with the Prolong Gold antifading reagent with DAPI, followed by analysis with an MRC1024 confocal laser scanning microscope (Bio-Rad). Western blot analysis. Protein extraction and Western blot analysis were performed as described in ref. 7 . Chemiluminescence detection for rat primary cortical neurons and MCNSCs was performed with a Luminescent Image Analyzer LAS-3000 (Fujifilm) and Multi Gauge (version 3.0) software and a VersaDoc Imaging System (Bio-Rad), respectively. Electron microscopy. Briefly, cells were plated in 35-mm dishes with a coverslip in the bottom and infected with lentivirus. After 48 h, cells were fixed in 2% paraformaldehyde and 1% glutaraldehyde, then fixed in osmium tetroxide and embedded in Epon araldite. Once the resin hardened, blocks with the cells were detached from the coverslips and mounted for sectioning with an ultramicrotome (Leica). Similarly, Vibratome sections from the ␣-syn transgenic mice injected with the MCNSCs or control were fixed, embedded, and sectioned with the ultramicrotome. Grids were analyzed with a Zeiss OM 10 electron microscope as described in ref. 8 . Three independent experiments were performed. At least 100 neurons were analyzed for each experiment ( * , P Ͻ 0.05). 
